.svg){kind=small}
Mar-2026
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In the Oregon market, Quality Drugs has shown a steady presence in the Edible category. Over the past few months, their ranking has hovered around the top 10, peaking in December 2025 at rank 9. Despite a slight dip to rank 11 in February 2026, they quickly regained their position by March 2026. This indicates a resilient performance in a competitive category. The sales figures reflect a similar pattern, with a notable increase in March 2026, suggesting a recovery after a couple of slower months. This consistent ranking within the top 15 highlights their strong foothold in the Oregon edibles market, though there is room for improvement to climb higher in the rankings.
Interestingly, the data reveals that Quality Drugs did not break into the top 30 brands in some other states and categories, which could be a point of concern or an opportunity for growth. Their absence from the rankings in these areas might suggest either a highly competitive landscape or a need for strategic adjustments to enhance their market presence. While the specific states and categories where they are not ranked are not detailed here, this information could be crucial for stakeholders looking to understand the broader performance of Quality Drugs across different markets. Exploring these gaps could provide insights into potential expansion strategies or areas requiring increased focus and resources.
Competitive Landscape
In the competitive landscape of the Oregon edible cannabis market, Quality Drugs has experienced notable fluctuations in its ranking and sales performance over the past few months. Starting from a rank of 9th in December 2025, Quality Drugs slipped to 10th in January 2026 and further to 11th in February, before recovering slightly to 10th in March. This indicates a competitive struggle, especially against brands like Hellavated, which maintained a consistent top 10 position, and Verdant Leaf Farms, which improved its rank from 10th to 8th by March. Despite these challenges, Quality Drugs' sales trajectory shows potential for recovery, as evidenced by the increase in sales from February to March. This competitive analysis suggests that while Quality Drugs faces stiff competition, particularly from brands like Verdant Leaf Farms and Private Stash, there remains an opportunity for strategic adjustments to regain and potentially improve its market position.
Notable Products
In March 2026, the top-performing product for Quality Drugs was the Cosmic Pop Gummy (100mg) in the Edible category, maintaining its number one rank consistently since December 2025, with a notable increase in sales to 6452 units. The Watermelon Gummy (100mg) rose to the second position, showing a steady climb from fifth in January 2026. The THC/CBD 2:1 Radiant Raspberry Gummy (100mg THC, 50mg CBD) held its ground at the third rank for two consecutive months. Mellow Mango Gummy (100mg) dropped to fourth place, after peaking at second in February 2026. Super Sour Apple Gummy (100mg) experienced a decline, moving from second in December 2025 to fifth in March 2026, indicating shifting consumer preferences within the Edible category.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
